Equillium (EQ) Cash & Equivalents (2017 - 2026)
Equillium's (EQ) quarterly Cash & Equivalents came in at $61.3 million in Q1 2026, up 322.91% year-on-year from $14.5 million in Q1 2025, and up 106.24% on a QoQ basis from $29.7 million in Q4 2025.
Equillium (EQ) Cash & Equivalents (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Cash & Equivalents data on file, last reported at $61.3 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 322.91% year-over-year to $61.3 million in Q1 2026; TTM through Mar 2026 was $61.3 million, a 322.91% increase from a year earlier, with the FY2025 full-year figure at $29.7 million, up 64.41% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $61.3 million, up from $29.7 million in the prior quarter.
- Over the last five years, Cash & Equivalents for EQ reached as high as $61.3 million in Q1 2026 and fell as low as $10.3 million in Q2 2025.
- Historically, Cash & Equivalents has averaged $26.3 million across 5 years, with a median of $24.5 million in 2023.
- Across the five-year window, Cash & Equivalents slumped 67.62% in 2022 and jumped 322.91% in 2026, its largest moves.
- Year by year, Cash & Equivalents stood at $59.1 million in 2022, then sank by 60.72% to $23.2 million in 2023, then slipped by 22.1% to $18.1 million in 2024, then soared by 64.41% to $29.7 million in 2025, then soared by 106.24% to $61.3 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $61.3 million in Q1 2026, $29.7 million in Q4 2025, and $33.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Equillium | 258.99 Mn | 258.99 Mn | - | 61.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.32 Mn |
| Dec 31, 2025 | 29.73 Mn |
| Sep 30, 2025 | 33.10 Mn |
| Jun 30, 2025 | 10.27 Mn |
| Mar 31, 2025 | 14.50 Mn |
| Dec 31, 2024 | 18.09 Mn |
| Sep 30, 2024 | 15.45 Mn |
| Jun 30, 2024 | 11.06 Mn |
| Mar 31, 2024 | 11.57 Mn |
| Dec 31, 2023 | 23.22 Mn |
| Sep 30, 2023 | 34.38 Mn |
| Jun 30, 2023 | 25.62 Mn |
| Mar 31, 2023 | 24.50 Mn |
| Dec 31, 2022 | 59.11 Mn |
| Sep 30, 2022 | 25.73 Mn |
| Jun 30, 2022 | 23.81 Mn |
| Mar 31, 2022 | 26.24 Mn |
| Dec 31, 2021 | 50.37 Mn |
| Sep 30, 2021 | 77.16 Mn |
| Jun 30, 2021 | 73.53 Mn |